BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7868955)

  • 1. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
    Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy.
    Pardillo FE; Burgos J; Fajardo TT; Dela Crux E; Abalos RM; Paredes RM; Andaya CE; Gelber RH
    Lepr Rev; 2009 Jun; 80(2):205-9. PubMed ID: 19743625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persister studies in leprosy patients after multi-drug treatment.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Katoch VM
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):100-4. PubMed ID: 16830652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of two doses of rifampin against Mycobacterium leprae.
    Husser JA; Traore I; Daumerie D
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical trial of minocycline in lepromatous leprosy.
    Gelber RH; Fukuda K; Byrd S; Murray LP; Siu P; Tsang M; Rea TH
    BMJ; 1992 Jan; 304(6819):91-2. PubMed ID: 1737148
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of low-level and intermittent minocycline therapy on the growth of Mycobacterium leprae in mice.
    Gelber RH; Siu P; Tsang M; Alley P; Murray LP
    Antimicrob Agents Chemother; 1991 May; 35(5):992-4. PubMed ID: 1854182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; Cruz EC; Cellona RV; Balagon MV; Abalos RM; Gelber RH
    Lepr Rev; 2004 Dec; 75(4):389-97. PubMed ID: 15685736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline lepromatous leprosy in an Italian man.
    Massone C; Clapasson A; Nunzi E
    Am J Trop Med Hyg; 2013 Feb; 88(2):211. PubMed ID: 23390219
    [No Abstract]   [Full Text] [Related]  

  • 17. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
    Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
    Ji B; Jamet P; Perani EG; Bobin P; Grosset JH
    J Infect Dis; 1993 Jul; 168(1):188-90. PubMed ID: 8257487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.